88 related articles for article (PubMed ID: 792331)
1. Antibody response to lymphoma antigens in syngeneic and H-2 compatible mice.
Dalton JG; Fujimoto S; Sehon AH
J Immunol; 1976 Nov; 117(5 Pt.2):1743-8. PubMed ID: 792331
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens.
Vlug A; Melief CJ; de Bruyne C; Schoenmakers H; Molenaar JL
J Natl Cancer Inst; 1980 May; 64(5):1191-8. PubMed ID: 6245302
[TBL] [Abstract][Full Text] [Related]
4. Regulation of antibody response to SRBC. II. Effect of a non-specific stimulation.
Ríhová B; Ríha I; Hofman J
Folia Biol (Praha); 1981; 27(1):15-27. PubMed ID: 7009228
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility antigens acting as helper determinants for tumor-associated antigens of murine lymphosarcoma.
Colnaghi MI
Eur J Immunol; 1975 Apr; 5(4):241-5. PubMed ID: 1086228
[TBL] [Abstract][Full Text] [Related]
6. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
Fujimoto S; Chen CH; Sabbadini E; Sehon AH
J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
[No Abstract] [Full Text] [Related]
7. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
10. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
Prager MD; Granatek CH; Ludden CM
Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
[TBL] [Abstract][Full Text] [Related]
11. Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells.
Callahan GN; Allison JP; Pellegrino MA; Reisfeld RA
J Immunol; 1979 Jan; 122(1):70-4. PubMed ID: 762424
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
14. Regulation of antibody response to SRBC. I. Influence of corpuscular and soluble form of erythrocyte antigen and antigen dose on antibody response in A/J and C57BL/10ScSn mice.
Ríhová B; Tucková L; Ríha I
Folia Biol (Praha); 1981; 27(1):1-14. PubMed ID: 7009227
[TBL] [Abstract][Full Text] [Related]
15. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
Lake JP; Kapp JA; Pierce CW
J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
[TBL] [Abstract][Full Text] [Related]
16. Effect of immune factors on the motility of lymphoma cells.
Cochran AJ; Klein E; Keissling R
J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
[No Abstract] [Full Text] [Related]
17. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
18. Ir-gene control of antibody class production.
Kolb H; Keck K; Momayezi M; Schicker C; Trissl D
J Immunol; 1977 Feb; 118(2):427-30. PubMed ID: 839064
[TBL] [Abstract][Full Text] [Related]
19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
20. Correlations between humoral immunity and successful chemotherapy-immunotherapy.
Cantrell JL; Killion JJ; Kollmorgen GM
Cancer Res; 1976 Sep; 36(9 pt.1):3051-7. PubMed ID: 788896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
